ZFHX3 and prostate carcinoma: Combined with the identification of somatic mutations in prostate cancer [9] these features are consistent with a tumor suppressor function for ATBF1. It has been suggested that in breast cancer, higher mRNA expression of ATBF1 is associated with a better prognosis, i.e. absence of tumor-positive lymph nodes [37].